Graham Capital Management, L.P. Krystal Biotech, Inc. Transaction History
Graham Capital Management, L.P.
- $5.08 Billion
- Q4 2024
A detailed history of Graham Capital Management, L.P. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 2,082 shares of KRYS stock, worth $382,921. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,082
Previous 2,231
6.68%
Holding current value
$382,921
Previous $405,000
19.51%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding KRYS
# of Institutions
300Shares Held
24.4MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$726 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$529 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$483 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$235 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$162 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.72B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...